Skip to content

Press releases

Discover latest product news and media coverage about Ultromics.

Showing posts for the author 'Ultromics (3)'

Show all
EchoGo Core 2.0: Next generation AI platform offers faster, more robust, holistic echo diagnostics, with over 230 measurements

EchoGo Core 2.0: Next generation AI platform offers faster, more robust, holistic echo diagnostics, with over 230 measurements

Ultromics announces the launch of EchoGo Core 2.0 – a new resource in the global fight against cardiovascular disease
Northumbria Healthcare NHS Foundation Trust using AI to help detect coronary artery disease

Northumbria Healthcare NHS Foundation Trust using AI to help detect coronary artery disease

Northumbria Healthcare NHS Foundation Trust using AI to help detect coronary artery disease
Artificial Intelligence improves coronary artery disease detection, new study finds

Artificial Intelligence improves coronary artery disease detection, new study finds

Breakthrough study shows AI is capable of independently reading stress echocardiograms and predicting coronary artery disease, significantly increasing detection compared to traditional methods.
Caption health and Ultromics partner to put heart disease detection and management tools in more hands

Caption health and Ultromics partner to put heart disease detection and management tools in more hands

Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
Ultromics announces collaboration with Janssen to develop AI for patients with amyloidosis with cardiac involvement

Ultromics announces collaboration with Janssen to develop AI for patients with amyloidosis with cardiac involvement

Ultromics Announces Collaboration with Janssen to Develop an AI-Powered Diagnostic Device for Patients with Amyloidosis with Cardiac Involvement
Ultromics raises $33M in series B Funding to help transform cardiac disease treatment

Ultromics raises $33M in series B Funding to help transform cardiac disease treatment

Ultromics Raises $33M in Series B Funding to Help Transform Cardiac Disease Treatment
EchoGo predicts cardiac-related COVID-19 mortality revealed in WASE study

EchoGo predicts cardiac-related COVID-19 mortality revealed in WASE study

EchoGo Supported Predictors of Cardiac-Related COVID-19 Mortality Revealed in WASE Study
Ultromics CE Mark's EchoGo Core

Ultromics CE Mark's EchoGo Core

EchoGo Core, the first and only platform to automate ultrasound analysis in the cloud, is now available for use in the UK and Europe
NHS AI Virtual Hub 'Show and Tell' series｜Ultromics

NHS AI Virtual Hub 'Show and Tell' series｜Ultromics

Learn more about how Ultromics' AI platform , EchoGo, is being deployed in the NHS, as part of the NHS AI Virtual Hub 'Show and Tell' sessions
NHS staff given easy access to cloud-based echocardiogram analysis

NHS staff given easy access to cloud-based echocardiogram analysis

Read more about how clinicians across the NHS can now access EchoGo, through NHS England’s Image Exchange Portal (IEP), to automate ultrasound analysis
EchoGo now available on the Microsoft Azure Marketplace

EchoGo now available on the Microsoft Azure Marketplace

Microsoft Azure customers worldwide now gain access to the Ultromics’ EchoGo service for automated echocardiography analysis.

Ultromics receives FDA clearance for EchoGo Pro; a first-of-kind solution to help diagnose CAD

Ultromics receives FDA clearance for EchoGo Pro; a first-of-kind solution to help diagnose CAD

A world-first, AI powered, outcomes-driven, decision support tool, EchoGo Pro, has been cleared by the FDA and is now available to clinicians across the U.S.

Curious about upcoming research and innovation?

Sign-up to hear about the latest news.

 

Sign up to newsletter

mail
534518

cases processed